Cart
sales@molnova.com
Orphenadrine
CAS No. 83-98-7
Orphenadrine( —— )
Catalog No. M36262 CAS No. 83-98-7
Orphenadrine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that inhibits clonal HERG channels in a concentration-dependent manner, producing an IC of 0.85 μM in HEK cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 101 | In Stock |
|
| 50MG | 145 | In Stock |
|
| 100MG | 212 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOrphenadrine
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrphenadrine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that inhibits clonal HERG channels in a concentration-dependent manner, producing an IC of 0.85 μM in HEK cells.
-
DescriptionOrphenadrine is a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist that inhibits clonal HERG channels in a concentration-dependent manner, producing an IC of 0.85 μM in HEK cells.Orphenadrine is an antagonist of central and peripheral muscarinic receptors. Attenuation is blocked by mutations in pore residues Y652 or F656. Orphenadrine has antispasmodic, analgesic, and anticholinergic activity and protects against glutamatergic neurotoxicity in vitro and in vivo.Orphenadrine has inhibitory effects on sodium channels and can be used in the treatment of Parkinson's disease.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
RecptorNMDAR | Sodium Channel | AChR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83-98-7
-
Formula Weight269.38
-
Molecular FormulaC18H23NO
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(OCCN(C)C)(C1=C(C)C=CC=C1)C2=CC=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BDBM50597431
BDBM50597431 is an NMDA receptor modulator that may have can be used to study Alzheimer's disease and Parkinson's syndrome.
-
Ro 25-6981
Ro 25-6981 is a potent and selective activity-dependent NMDA receptors blocker containing the NR2B subunit with IC50s of 0.009 and 52 μM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively. Ro 25-6981 can be used in studies about Parkinson's disease.
-
Dextrorphan (tartrat...
Dextrophan tartrate is a glutamate receptor antagonist potentially for the treatment of stroke.
